Wolverine Trading
IHE icon

Wolverine Trading’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Wolverine Trading’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,400
Closed -$537K – 4608
2016
Q4 		$537K Sell
11,400
-900
-7% -$42.7K ﹤0.01% 2540
2016
Q3 		$608K Buy
12,300
+6,900
+128% +$350K ﹤0.01% 2376
2016
Q2 		$259K Buy
+5,400
New +$257K ﹤0.01% 2979

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Wolverine Trading's IHE Position: Q4 2019 in Review

Wolverine Trading sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2019, closing a stake of 4,614 shares — an estimated $227K sold.

Wolverine Trading first reported a position in IHE in Q4 2016 and held it in 2 quarters. The position peaked at $436K in Q4 2016. 95 funds tracked by Wall St. Rank hold IHE as of Q4 2019.

  • Wolverine Trading reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2019 after selling out during the quarter.
  • Wolverine Trading sold 4,614 iShares US Pharmaceuticals ETF shares in Q4 2019, an estimated $227K.
  • Wolverine Trading first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and held it in 2 quarters.
  • Wolverine Trading's iShares US Pharmaceuticals ETF position peaked at $436K in Q4 2016.
  • 95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.